Skip to content

Johannes G. Ramaekers

Maastricht University

114 papers in the library · 4,340 citations · publishing 2003-2026

Papers

Sort Most recent Most cited

Psilocybin and 2C-B at Encoding Distort Episodic Familiarity.

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging October 1, 2024 Manoj K. Doss, Pablo Mallaroni, Natasha L. Mason et al. 7 citations

As research on psychedelics (hallucinogenic serotonin receptor 2A agonists) progresses, it is important to delineate the reliability of supposedly unique effects across this drug class. One such effect is how psychedelics impair the formation (i.e., encoding) of hippocampal-dependent recollections (retrieval of specific details) while potentially enhancing the encoding of cortical-dependent...

Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions.

European Neuropsychopharmacology August 1, 2024 Zeus Tipado, Kim P. C. Kuypers, Bettina Sorger et al. 5 citations

Psychedelics like LSD (Lysergic acid diethylamide) and psilocybin are known to modulate perceptual modalities due to the activation of mostly serotonin receptors in specific cortical (e.g., visual cortex) and subcortical (e.g., thalamus) regions of the brain. In the visual domain, these psychedelic modulations often result in peculiar disturbances of viewed objects and light and sometimes even...

DOI: 10.1016/j.euroneuro.2024.04.011 (opens in new tab) Full text (opens in new tab) Psychedelic research Retinal biology Amacrine cells Psychedelics +3

Inter-individual variability in neural response to low doses of LSD.

Translational Psychiatry July 15, 2024 Nadia R. P. W. Hutten, Conny W.E.M. Quaedflieg, Natasha L. Mason et al. 16 citations

The repeated use of small doses of psychedelics (also referred to as "microdosing") to facilitate benefits in mental health, cognition, and mood is a trending practice. Placebo-controlled studies however have largely failed to demonstrate strong benefits, possibly because of large inter-individual response variability. The current study tested the hypothesis that effects of low doses of LSD on...

Dynamic Functional Hyperconnectivity After Psilocybin Intake Is Primarily Associated With Oceanic Boundlessness.

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging July 1, 2024 Sepehr Mortaheb, Larry D. Fort, Natasha L. Mason et al. 15 citations

Psilocybin is a widely studied psychedelic substance that leads to the psychedelic state, a specific altered state of consciousness. To date, the relationship between the psychedelic state's neurobiological and experiential patterns remains undercharacterized because they are often analyzed separately. We investigated the relationship between neurobiological and experiential patterns after...

Recreational Nitrous Oxide Dosing and Administration and Its Use in Traffic: An Online Survey

Journal of Drug Issues February 24, 2024 Frederick Vinckenbosch, Eef L. Theunissen, Agnieszka Stelling et al. 2 citations

Nitrous oxide (N2O) is a popular recreational intoxicant and associated paraphernalia are increasingly being found at road traffic accident scenes in the Netherlands, suggesting that N 2 O intoxication causally contributes to the occurrence of a significant number of road traffic accidents. However, information on the pharmacodynamics- and kinetic characteristics of recreational N2O use is...

DOI: 10.1177/00220426241233193 (opens in new tab) Full text (opens in new tab) Dosing Recreational use Administration probate law Nitrous oxide +5

Shared functional connectome fingerprints following ritualistic ayahuasca intake.

Neuroimage 2024 Pablo Mallaroni, Natasha L. Mason, Lilian Kloft et al. 17 citations

The knowledge that brain functional connectomes are unique and reliable has enabled behaviourally relevant inferences at a subject level. However, whether such "fingerprints" persist under altered states of consciousness is unknown. Ayahuasca is a potent serotonergic psychedelic which produces a widespread dysregulation of functional connectivity. Used communally in religious ceremonies, its...

DOI: 10.1016/j.neuroimage.2023.120480 (opens in new tab) Full text (opens in new tab) DMT Entheogens Brain connectivity connectome Neuroimaging FMRI +8

Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie December 31, 2023 Francisco Madrid-Gambin, David Fabregat-Safont, Alex Gomez-Gomez et al. 12 citations

Psychedelics are classical hallucinogen drugs that induce a marked altered state of consciousness. In recent years, there has been renewed attention to the possible use of classical psychedelics for the treatment of certain mental health disorders. However, further investigation to better understand their biological effects in humans, their mechanism of action, and their metabolism in humans is...

Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans

Biomedicine & Pharmacotherapy December 31, 2023 David Fabregat-Safont, Alex Gomez-Gomez, Francisco Madrid-Gambin et al.

Psychedelics are classical hallucinogen drugs that induce a marked altered state of consciousness. In recent years, there has been renewed attention to the possible use of classical psychedelics for the treatment of certain mental health disorders. However, further investigation to better understand their biological effects in humans, their mechanism of action, and their metabolism in humans is...

The unique neural signature of your trip: Functional connectome fingerprints of subjective psilocybin experience

Network Neuroscience November 1, 2023 Juan Carlos Farah, Pablo Mallaroni, Enrico Amico et al. 21 citations

Abstract The emerging neuroscientific frontier of brain fingerprinting has recently established that human functional connectomes (FCs) exhibit fingerprint-like idiosyncratic features, which map onto heterogeneously distributed behavioral traits. Here, we harness brain-fingerprinting tools to extract FC features that predict subjective drug experience induced by the psychedelic psilocybin....

Cortical structural differences following repeated ayahuasca use hold molecular signatures

Frontiers in Neuroscience October 5, 2023 Pablo Mallaroni, Lilian Kloft, Natasha L. Mason et al. 8 citations

Introduction Serotonergic psychedelics such as ayahuasca are reported to promote both structural and functional neural plasticity via partial 5-HT 2A agonism. However, little is known about how these molecular mechanisms may extend to repeated psychedelic administration in humans, let alone neuroanatomy. While early evidence suggests localised changes to cortical thickness in long-term...

Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study

Brain, Behavior, and Immunity September 7, 2023 Natasha L. Mason, Attila Szabo, Kim P. C. Kuypers et al. 83 citations

Patients characterized by stress-related disorders such as depression display elevated circulating concentrations of pro-inflammatory cytokines and a hyperactive HPA axis. Psychedelics are demonstrating promising results in treatment of such disorders, however the mechanisms of their therapeutic effects are still unknown. To date the evidence of acute and persisting effects of psychedelics on...

Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study

European Journal of Pain August 20, 2023 Mauro Cavarra, Amanda Feilding, Pamela Kryskow et al. 28 citations

Abstract Background Chronic pain is a major cause of suffering and disability and is often associated with psychiatric complications. Current treatments carry the risk of severe side effects and may lead to limited or no relief at all in a relevant portion of this patient population. Preliminary evidence suggests that classical psychedelics (e.g. LSD and psilocybin) may have analgesic effects...

DOI: 10.1002/ejp.2171 (opens in new tab) Sciatica Chronic pain Analgesic Observational study +5

Acute effects of Δ9-tetrahydrocannabinol (THC) on resting state connectivity networks and impact of COMT genotype: A multi-site pharmacological fMRI study

Drug and Alcohol Dependence August 11, 2023 Teuntje A. D. Pelgrim, Johannes G. Ramaekers, Matthew B. Wall et al. 3 citations

BACKGROUND: Cannabis produces various acute psychotropic effects, with marked individual differences. Cannabis use is a risk factor for developing psychotic disorders. The main component responsible for these effects is Δ9-tetrahydrocannabinol (THC). Here we investigated the neural basis of acute THC effects and its modulation by catechol-methyl-transferase (COMT) Val158Met genotype. METHODS:...

Harnessing placebo: Lessons from psychedelic science.

Journal of Psychopharmacology June 30, 2023 Chloé Pronovost-Morgan, Ido Hartogsohn, Johannes G. Ramaekers 33 citations

The randomized controlled trial (RCT) research design assumes that a drug's "specific" effect can be isolated, added, and subtracted from the "nonspecific" effect of context and person. While RCTs are helpful in assessing the added benefit of a novel drug, they tend to obscure the curative potential of extra-pharmacological variables, known as "the placebo effect." Ample empirical evidence...

A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression

Frontiers in Psychiatry June 20, 2023 Johannes T. Reckweg, Cees van Leeuwen, Cécile Henquet et al. 86 citations

Background Treatment-resistant depression (TRD) is a substantial public health burden, but current treatments have limited effectiveness. The aim was to investigate the safety and potential antidepressant effects of the serotonergic psychedelic drug 5-MeO-DMT in a vaporized formulation (GH001) in adult patients with TRD. Methods The Phase 1 part ( n = 8) of the trial investigated two single...

Assessment of the Acute Effects of 2C‐B vs. Psilocybin on Subjective Experience, Mood, and Cognition

Clinical Pharmacology & Therapeutics May 30, 2023 Pablo Mallaroni, Riccardo Paci, Sabrina Ritscher et al. 34 citations

2,5‐dimethoxy‐4‐bromophenethylamine (2C‐B) is a hallucinogenic phenethylamine derived from mescaline. Observational and preclinical data have suggested it to be capable of producing both subjective and emotional effects on par with other classical psychedelics and entactogens. Whereas it is the most prevalently used novel serotonergic hallucinogen to date, it's acute effects and distinctions...

Altered State of Consciousness and Mental Imagery as a Function of N, N-dimethyltryptamine Concentration in Ritualistic Ayahuasca Users

Journal of Cognitive Neuroscience 2023 Johannes G. Ramaekers, Pablo Mallaroni, Lilian Kloft et al. 15 citations

Abstract Consumption of the psychedelic brew ayahuasca is a central ritualistic aspect of the Santo Daime religion. The current observational, baseline controlled study was designed to assess whether members (n = 24) of the Santo Daime church would show enhanced capacity for mental imagery during an ayahuasca experience. In addition, this study assessed whether the effects of ayahuasca on...

DOI: 10.1162/jocn_a_02003 (opens in new tab) Ayahuasca DMT Psychedelics Consciousness research +1

Altered States of Consciousness During Ceremonial San Pedro Use

International Journal for the Psychology of Religion December 5, 2022 Arne Bohn, Michiel H. H. Kiggen, Malin V. Uthaug et al. 10 citations

San Pedro, a mescaline containing cactus, has been used for thousands of years and is currently popular as a psychedelic substance in ceremonial retreats in Europe. The current research investigates the consciousness altering effects of San Pedro. Forty-two participants who joined ceremonial psychedelic retreats in the Netherlands were investigated with questionnaires probing 11 dimensions of...

Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers

medRxiv November 1, 2022 Natasha L. Mason, Attila Szabo, Kim P. C. Kuypers et al. 6 citations preprint

Abstract Patients characterized by stress-related disorders such as depression display elevated circulating concentrations of pro-inflammatory cytokines and a hyperactive HPA axis. Psychedelics are demonstrating promising results in treatment of such disorders, however the mechanisms of their therapeutic effects are still unknown. To date the evidence of acute and persisting effects of...

Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis

Psychopharmacology October 13, 2022 Nadia R. P. W. Hutten, Thomas R. Arkell, Frederick Vinckenbosch et al. 36 citations

RATIONALE: Delta-9-tetrahydrocannabinol (THC), an active component of cannabis, can cause anxiety in some users during intoxication. Cannabidiol (CBD), another constituent of cannabis, has anxiolytic properties suggesting that cannabis products containing CBD in addition to THC may produce less anxiety than THC-only products. Findings to date around this issue have been inconclusive and could...

Ritualistic use of ayahuasca enhances a shared functional connectome identity with others

bioRxiv (Cold Spring Harbor Laboratory) October 11, 2022 Pablo Mallaroni, Natasha L. Mason, Lilian Kloft et al. 4 citations preprint

Abstract The knowledge that brain functional connectomes are both unique and reliable has enabled behaviourally relevant inferences at a subject level. However, it is unknown whether such “fingerprints” persist under altered states of consciousness. Ayahuasca is a potent serotonergic psychedelic which elicits a widespread dysregulation of functional connectivity. Used communally in religious...

The influence of ceremonial settings on mystical and challenging experiences occasioned by ayahuasca: A survey among ritualistic and religious ayahuasca users

Frontiers in Psychology July 15, 2022 Alexandre Augusto de Deus Pontual, Alexandre Augusto de Deus Pontual, Luís Fernando Tófoli et al. 27 citations

Recent studies have recognized the importance of non-pharmacological factors such as setting to induce or promote mystical experiences or challenging experiences among ayahuasca users. This study aimed to evaluate the association between the setting in which ayahuasca is consumed and the intensity of mystical and challenging experiences considering three ayahuasca using traditions (União do...

DOI: 10.3389/fpsyg.2022.857372 (opens in new tab) Full text (opens in new tab) Udv Neo-shamanic Mystical experiences Ayahuasca-ceremony ayahuasca ritual +6

Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey.

British Journal of Pain July 14, 2022 Valerie Bonnelle, Will J Smith, Natasha L. Mason et al. 26 citations

Although several studies and reports have shown the potential analgesic use of serotonergic psychedelics in cancer pain, phantom limb pain and cluster headache, evidence supporting their use for chronic pain is still limited. The past years have seen a considerable renewal of interest toward the therapeutic use of these compounds for mood disorders, resulting in a marked increase in the number...

DOI: 10.1177/20494637221114962 (opens in new tab) Full text (opens in new tab) Psychedelics: classical psychedelics Hallucinogens Entheogens Psychotropics +9

Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees

Frontiers in Psychiatry July 7, 2022 Maggie Kiraga, Kim P. C. Kuypers, Malin V. Uthaug et al. 24 citations

Anxiety disorders are the most common type of psychiatric disorders among Western countries. Evidence-based treatment modalities including pharmacological and cognitive-behavioral therapy result in deficient treatment responses. Historical and recent research suggests psychedelic drugs may be efficacious in alleviating anxiety-related symptoms among healthy and clinical populations. The main...

Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.

Neuroscience & Biobehavioral Reviews July 1, 2022 Drummond E-Wen Mcculloch, Gitte Moos Knudsen, Frederick Streeter Barrett et al. 14 citations

Clinical research into serotonergic psychedelics is expanding rapidly, showing promising efficacy across myriad disorders. Resting-state functional magnetic resonance imaging (rs-fMRI) is a commonly used strategy to identify psychedelic-induced changes in neural pathways in clinical and healthy populations. Here we, a large group of psychedelic imaging researchers, review the 42 research...